TY - JOUR
T1 - Fundamental principles of an effective diabetic retinopathy screening program
AU - the Vision Academy
AU - Lanzetta, Paolo
AU - Sarao, Valentina
AU - Scanlon, Peter H.
AU - Barratt, Jane
AU - Porta, Massimo
AU - Bandello, Francesco
AU - Loewenstein, Anat
AU - Eldem, Bora
AU - Hunyor, Alex
AU - Joussen, Antonia
AU - Koh, Adrian
AU - Korobelnik, Jean François
AU - Lövestam-Adrian, Monica
AU - Navarro, Rafael
AU - Okada, Annabelle A.
AU - Pearce, Ian
AU - Rodríguez, Francisco J.
AU - Staurenghi, Giovanni
AU - Wolf, Sebastian
AU - Wong, David T.
N1 - Publisher Copyright:
© 2020, The Author(s).
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Background: Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR. Methods: A working group of ophthalmic and diabetes experts was established to develop a consensus on the key principles of an effective DR screening program. Recommendations are based on analysis of a structured literature review. Results: The recommendations for implementing an effective DR screening program are: (1) Examination methods must be suitable for the screening region, and DR classification/grading systems must be systematic and uniformly applied. Two-field retinal imaging is sufficient for DR screening and is preferable to seven-field imaging, and referable DR should be well defined and reliably identifiable by qualified screening staff; (2) in many countries/regions, screening can and should take place outside the ophthalmology clinic; (3) screening staff should be accredited and show evidence of ongoing training; (4) screening programs should adhere to relevant national quality assurance standards; (5) studies that use uniform definitions of risk to determine optimum risk-based screening intervals are required; (6) technology infrastructure should be in place to ensure that high-quality images can be stored securely to protect patient information; (7) although screening for diabetic macular edema (DME) in conjunction with DR evaluations may have merit, there is currently insufficient evidence to support implementation of programs solely for DME screening. Conclusion: Use of these recommendations may yield more effective DR screening programs that reduce the risk of vision loss worldwide.
AB - Background: Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR. Methods: A working group of ophthalmic and diabetes experts was established to develop a consensus on the key principles of an effective DR screening program. Recommendations are based on analysis of a structured literature review. Results: The recommendations for implementing an effective DR screening program are: (1) Examination methods must be suitable for the screening region, and DR classification/grading systems must be systematic and uniformly applied. Two-field retinal imaging is sufficient for DR screening and is preferable to seven-field imaging, and referable DR should be well defined and reliably identifiable by qualified screening staff; (2) in many countries/regions, screening can and should take place outside the ophthalmology clinic; (3) screening staff should be accredited and show evidence of ongoing training; (4) screening programs should adhere to relevant national quality assurance standards; (5) studies that use uniform definitions of risk to determine optimum risk-based screening intervals are required; (6) technology infrastructure should be in place to ensure that high-quality images can be stored securely to protect patient information; (7) although screening for diabetic macular edema (DME) in conjunction with DR evaluations may have merit, there is currently insufficient evidence to support implementation of programs solely for DME screening. Conclusion: Use of these recommendations may yield more effective DR screening programs that reduce the risk of vision loss worldwide.
KW - Diabetic retinopathy screening
KW - Evidence-based recommendations
KW - Telemedicine
UR - http://www.scopus.com/inward/record.url?scp=85082966727&partnerID=8YFLogxK
U2 - 10.1007/s00592-020-01506-8
DO - 10.1007/s00592-020-01506-8
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 32222818
AN - SCOPUS:85082966727
SN - 0940-5429
VL - 57
SP - 785
EP - 798
JO - Acta Diabetologica
JF - Acta Diabetologica
IS - 7
ER -